BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 2209540)

  • 21. Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1.
    Blumenthal SG; Aichele G; Wirth T; Czernilofsky AP; Nordheim A; Dittmer J
    J Biol Chem; 1999 Apr; 274(18):12910-6. PubMed ID: 10212281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular and functional characterization of the promoter of ETS2, the human c-ets-2 gene.
    Mavrothalassitis GJ; Watson DK; Papas TS
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):1047-51. PubMed ID: 2405393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence specific binding of the transcription factor c-Ets1 to the human immunodeficiency virus type I long terminal repeat.
    Holzmeister J; Ludewig B; Pauli G; Simon D
    Biochem Biophys Res Commun; 1993 Dec; 197(3):1229-33. PubMed ID: 8280137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene.
    Kopp JL; Wilder PJ; Desler M; Kim JH; Hou J; Nowling T; Rizzino A
    J Biol Chem; 2004 May; 279(19):19407-20. PubMed ID: 14976186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myb and Ets related transcription factors are required for activity of the human lck type I promoter.
    McCracken S; Leung S; Bosselut R; Ghysdael J; Miyamoto NG
    Oncogene; 1994 Dec; 9(12):3609-15. PubMed ID: 7970721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK; Robinson L; Hodge DR; Kola I; Papas TS; Seth A
    Oncogene; 1997 Jan; 14(2):213-21. PubMed ID: 9010223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of a Ets1 variant protein unaffected in its chromatin and in vitro DNA binding capacities by T cell antigen receptor triggering and intracellular calcium rises.
    Pognonec P; Boulukos KE; Bosselut R; Boyer C; Schmitt-Verhulst AM; Ghysdael J
    Oncogene; 1990 Apr; 5(4):603-10. PubMed ID: 2183162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A residue of the ETS domain mutated in the v-ets oncogene is essential for the DNA-binding and transactivating properties of the ETS-1 and ETS-2 proteins.
    Soudant N; Albagli O; Dhordain P; Flourens A; Stéhelin D; Leprince D
    Nucleic Acids Res; 1994 Sep; 22(19):3871-9. PubMed ID: 7937106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ets1, when fused to the GAL4 DNA binding domain, efficiently enhances galactose promotor dependent gene expression in yeast.
    Seneca S; Punyammalee B; Bailly M; Ghysdael J; Crabeel M
    Oncogene; 1991 Mar; 6(3):357-60. PubMed ID: 1901401
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques.
    Robinson L; Panayiotakis A; Papas TS; Kola I; Seth A
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7170-5. PubMed ID: 9207063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ets transcription factors and targets in osteogenesis.
    Raouf A; Seth A
    Oncogene; 2000 Dec; 19(55):6455-63. PubMed ID: 11175361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective infection of human T-lymphotropic virus type 1 (HTLV-1)-infected cells by chimeric human immunodeficiency viruses containing HTLV-1 tax response elements in the long terminal repeat.
    Lin HC; Bodkin M; Lal RB; Rabson AB
    J Virol; 1995 Nov; 69(11):7216-25. PubMed ID: 7474143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantigen Ku protein is involved in DNA binding proteins which recognize the U5 repressive element of human T-cell leukemia virus type I long terminal repeat.
    Okumura K; Takagi S; Sakaguchi G; Naito K; Minoura-Tada N; Kobayashi H; Mimori T; Hinuma Y; Igarashi H
    FEBS Lett; 1994 Dec; 356(1):94-100. PubMed ID: 7988730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40tax protein in the human T-cell line, Jurkat.
    Nagata K; Ohtani K; Nakamura M; Sugamura K
    J Virol; 1989 Aug; 63(8):3220-6. PubMed ID: 2501514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.
    Wasylyk C; Gutman A; Nicholson R; Wasylyk B
    EMBO J; 1991 May; 10(5):1127-34. PubMed ID: 1850695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Twenty-one base pair repeat elements influence the ability of a Gal4-Tax fusion protein to transactivate the HTLV-I long terminal repeat.
    Connor LM; Oxman MN; Brady JN; Marriott SJ
    Virology; 1993 Aug; 195(2):569-77. PubMed ID: 8337832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indirect binding of human T-cell leukemia virus type I tax1 to a responsive element in the viral long terminal repeat.
    Marriott SJ; Boros I; Duvall JF; Brady JN
    Mol Cell Biol; 1989 Oct; 9(10):4152-60. PubMed ID: 2555684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 36-kilodalton cellular transcription factor mediates an indirect interaction of human T-cell leukemia/lymphoma virus type I TAX1 with a responsive element in the viral long terminal repeat.
    Marriott SJ; Lindholm PF; Brown KM; Gitlin SD; Duvall JF; Radonovich MF; Brady JN
    Mol Cell Biol; 1990 Aug; 10(8):4192-201. PubMed ID: 2370863
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional activation through ETS domain binding sites in the cytochrome c oxidase subunit IV gene.
    Virbasius JV; Scarpulla RC
    Mol Cell Biol; 1991 Nov; 11(11):5631-8. PubMed ID: 1656236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of protein kinase A in tax transactivation of the human T-cell leukemia virus type I long terminal repeat.
    Kadison P; Poteat HT; Klein KM; Faller DV
    J Virol; 1990 May; 64(5):2141-8. PubMed ID: 2157876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.